Delivery Order SPE2DB22D2009-SPE2DB25FL9QY
Award Date
6/10/25
Potential Completion Date
6/11/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,484.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of lisdexamfetamine 30 mg capsules, which are used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 6, 2025. Amerisourcebergen holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,885.07 contract is for the delivery of Lisdexamfetamine 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 20, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of lisdexamfetamine 60 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a delivery order with a firm fixed-price pricing type and a ceiling value of $4,008.24. The contract does not have a set-aside designation, indicating open...
This federal contract award, valued at $7,192.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lisdexamfetamine 30 mg capsules, a medication used to treat conditions such as Attention Deficit Hyperactivity Disorder (ADHD). The contract has a completion date of February 28, 2025 and is structured as a Firm Fixed Price Delivery Order. AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,149.73 fixed-price delivery order is for the supply of Lisdexamfetamine 30 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award is not associated with a set-aside program and is not part of a larger contract vehicle. However, Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $2,853.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lisdexamfetamine 20 mg capsules, a medication used to treat ADHD, with a performance period through May 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 capsules of 20 mg Lisdexamfetamine, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $2,140.49 and is a Firm Fixed Price Delivery Order with a completion date of March 12, 2025. The contract is not designated as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,420.35 firm-fixed-price delivery order is for the supply of 100 capsules of lisdexamfetamine 40 mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of June 4, 2025 and was awarded on June 3, 2025. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lisdexamfetamine 20 mg capsules, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $6,122.59 and is a firm fixed-price contract with a period of performance ending on May 5, 2025. This contract is not set aside for any...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 counts of 10 mg Lisdexamfetamine capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed price of $2,811.76 and a completion date of May 23, 2025. This contract is not designated as a set-aside....